Please use this identifier to cite or link to this item:
https://scidar.kg.ac.rs/handle/123456789/12454
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.rights.license | restrictedAccess | - |
dc.contributor.author | Vujic J. | - |
dc.contributor.author | Kaluđerović, Goran | - |
dc.contributor.author | Stanojkovic, Tatjana | - |
dc.contributor.author | Antic J. | - |
dc.contributor.author | Trifunović, Srećko | - |
dc.date.accessioned | 2021-04-20T20:52:38Z | - |
dc.date.available | 2021-04-20T20:52:38Z | - |
dc.date.issued | 2014 | - |
dc.identifier.issn | 1570-1808 | - |
dc.identifier.uri | https://scidar.kg.ac.rs/handle/123456789/12454 | - |
dc.description.abstract | Cytotoxic activity of four O,O′-dialkyl esters of ethylene-bis(S)-leucine [(S,S)-ethylenediamine-N,N'-di-2-(4- methyl)pentanoic acid] dihydrochlorides, R2edda-type esters L1·2HCl- L4·2HCl (alkyl = Et, n-Pr, n-Bu, and n-Pe, respectively), and corresponding palladium(II) (1-4) and platinum(II) (5-8) complexes against MDA-MB-361, MDA-MB-453 (human breast cancer), Jurkat (T-leukemia) and K562 (chronic myelogenous leukaemia) cell lines were determined. Results indicate cytotoxic potential of the investigated complexes based on induction of apoptosis. © 2014 Bentham Science Publishers. | - |
dc.rights | info:eu-repo/semantics/restrictedAccess | - |
dc.source | Letters in Drug Design and Discovery | - |
dc.title | In vitro antitumoral activity of palladium(II) and platinum(II) complexes with O,O′-dialkyl esters of ethylene-bis(S)-leucine | - |
dc.type | article | - |
dc.identifier.doi | 10.2174/15701808113106660092 | - |
dc.identifier.scopus | 2-s2.0-84898749274 | - |
Appears in Collections: | Faculty of Science, Kragujevac |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
PaperMissing.pdf Restricted Access | 29.86 kB | Adobe PDF | View/Open |
Items in SCIDAR are protected by copyright, with all rights reserved, unless otherwise indicated.